Collaboration between Family Physicians and Specialists in the Diagnosis and Management of Familial Hypercholesterolemia.

Kazuhiko Kotani
{"title":"Collaboration between Family Physicians and Specialists in the Diagnosis and Management of Familial Hypercholesterolemia.","authors":"Kazuhiko Kotani","doi":"10.15280/jlm.2021.11.2.94","DOIUrl":null,"url":null,"abstract":"Dear Sir, We read with great interest the report, written by Patel and Curnew, concerning the case of a patient with mixed hyperlipidemia for whom lifestyle treatment was effective [1]. The patient was initially diagnosed as familial hypercholesterolemia (FH) by a family physician and received pharmacological treatment with a proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) [1]. The report is instructive on the clinical practice in relation to FH and phenotypically confusing conditions. One of the confusing conditions was a case of hypercholesterolemia combined with hypertriglyceridemia as reported by Patel and Curnew [1]. We would like to add some further comments regarding the collaboration between family physicians and specialists. As the frequency of FH, an inherited disorder associated with an increased risk of cardiovascular diseases, is high in the community worldwide, family physicians play a key role in the screening and management of FH [2]. However, for family physicians who diagnose and manage FH patients, it is occasionally difficult clearly distinguish between some FH-like dyslipidemias and definitive FH [3]. In fact, we have also experienced some cases of secondary dyslipidemia with high cholesterol concentrations, like FH, for instance due to hypothyroidism, in which treatment using PCSK9i was attempted by family physicians. To assist in the clinical practice in relation to FH and FH-like dyslipidemias, collaboration between family physicians and specialists should be promoted. Guidelines, including more concrete practice in relation to FH and FH-like dyslipidemias, as well as a policy of collaboration with specialists, would be necessary for family physicians. Consultation systems to increase access to specialists using information and communication technologies, such as telemedicine, the Internet, and electronic record evaluation [4-6], may be arranged in the near future.","PeriodicalId":73805,"journal":{"name":"Journal of lifestyle medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/54/jlm-11-2-94.PMC8430315.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of lifestyle medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15280/jlm.2021.11.2.94","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Sir, We read with great interest the report, written by Patel and Curnew, concerning the case of a patient with mixed hyperlipidemia for whom lifestyle treatment was effective [1]. The patient was initially diagnosed as familial hypercholesterolemia (FH) by a family physician and received pharmacological treatment with a proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) [1]. The report is instructive on the clinical practice in relation to FH and phenotypically confusing conditions. One of the confusing conditions was a case of hypercholesterolemia combined with hypertriglyceridemia as reported by Patel and Curnew [1]. We would like to add some further comments regarding the collaboration between family physicians and specialists. As the frequency of FH, an inherited disorder associated with an increased risk of cardiovascular diseases, is high in the community worldwide, family physicians play a key role in the screening and management of FH [2]. However, for family physicians who diagnose and manage FH patients, it is occasionally difficult clearly distinguish between some FH-like dyslipidemias and definitive FH [3]. In fact, we have also experienced some cases of secondary dyslipidemia with high cholesterol concentrations, like FH, for instance due to hypothyroidism, in which treatment using PCSK9i was attempted by family physicians. To assist in the clinical practice in relation to FH and FH-like dyslipidemias, collaboration between family physicians and specialists should be promoted. Guidelines, including more concrete practice in relation to FH and FH-like dyslipidemias, as well as a policy of collaboration with specialists, would be necessary for family physicians. Consultation systems to increase access to specialists using information and communication technologies, such as telemedicine, the Internet, and electronic record evaluation [4-6], may be arranged in the near future.
家庭医生和专家在家族性高胆固醇血症的诊断和管理中的合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信